Dimensional Fund Advisors LP Beam Therapeutics Inc. Transaction History

Dimensional Fund Advisors LP

$449 Billion
Q3 2025

A detailed history of Dimensional Fund Advisors LP transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 1,720,290 shares of BEAM stock, worth $37.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,720,290

Previous 1,758,669 2.18%

Holding current value

$37.9 Million

Previous $29.9 Million 39.57%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$16.01 - $25.1 $614,447 - $963,312	-38,379 Reduced 2.18%	1,720,290 $41.8 Million
Q2 2025 Aug 12, 2025	BUY	$14.54 - $20.24 $2.36 Million - $3.29 Million	162,617 Added 10.19%	1,758,669 $29.9 Million
Q1 2025 May 13, 2025	BUY	$19.53 - $34.09 $1.13 Million - $1.97 Million	57,654 Added 3.75%	1,596,052 $31.2 Million
Q4 2024 Feb 13, 2025	BUY	$21.55 - $30.35 $6.42 Million - $9.05 Million	298,067 Added 24.03%	1,538,398 $38.2 Million
Q3 2024 Nov 07, 2024	BUY	$22.57 - $33.14 $4.31 Million - $6.33 Million	190,971 Added 18.2%	1,240,331 $30.4 Million

Q2 2024 Aug 09, 2024	BUY	$21.22 - $32.66 $8.65 Million - $13.3 Million	407,499 Added 63.49%	1,049,360 $24.6 Million
Q1 2024 May 10, 2024	BUY	$23.46 - $45.07 $1.76 Million - $3.38 Million	75,003 Added 13.23%	641,861 $21.2 Million
Q4 2023 Feb 07, 2024	BUY	$17.69 - $30.76 $2.65 Million - $4.61 Million	149,851 Added 35.93%	566,858 $15.4 Million
Q3 2023 Nov 09, 2023	BUY	$23.01 - $32.46 $3.05 Million - $4.3 Million	132,381 Added 46.51%	417,007 $10 Million
Q2 2023 Aug 09, 2023	BUY	$29.32 - $35.99 $3.06 Million - $3.75 Million	104,255 Added 57.8%	284,626 $9.09 Million
Q1 2023 May 12, 2023	BUY	$30.15 - $48.79 $1.69 Million - $2.73 Million	55,946 Added 44.96%	180,371 $5.52 Million
Q4 2022 Feb 09, 2023	BUY	$36.73 - $51.6 $4.04 Million - $5.68 Million	110,050 Added 765.57%	124,425 $4.87 Million
Q3 2022 Nov 10, 2022	SELL	$39.79 - $70.31 $149,371 - $263,943	-3,754 Reduced 20.71%	14,375 $685,000
Q2 2022 Aug 12, 2022	SELL	$29.86 - $62.36 $13,227 - $27,625	-443 Reduced 2.39%	18,129 $702,000
Q1 2022 May 13, 2022	BUY	$53.73 - $82.16 $425,004 - $649,885	7,910 Added 74.19%	18,572 $1.06 Million
Q4 2021 Feb 09, 2022	BUY	$68.02 - $99.06 $20,065 - $29,222	295 Added 2.85%	10,662 $850,000
Q3 2021 Nov 12, 2021	BUY	$84.37 - $133.6 $412,231 - $652,769	4,886 Added 89.14%	10,367 $902,000
Q2 2021 Aug 12, 2021	SELL	$64.12 - $128.71 $1,154 - $2,316	-18 Reduced 0.33%	5,481 $705,000
Q1 2021 May 14, 2021	BUY	$71.28 - $120.75 $391,968 - $664,004	5,499 New	5,499 $440,000

Others Institutions Holding BEAM

# of Institutions

249

Shares Held

95M

Call Options Held

888K

Put Options Held

549K

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.55B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Beam Therapeutics Inc. Transaction History